8
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36765 |
Palmitelaidic Acid methyl ester
|
||
Palmitoleic acid is a common constituent of the triglycerides of human adipose tissue. Palmitoleic acid-based diets raise low-density lipoprotein cholesterol and diminish high-density lipoprotein cholesterol, even when dietary intake of cholesterol is maintained at a low level. Palmitelaidic acid is the trans isomer of the 16:1 fatty acid palmitoleic acid. While its effects on cholesterol levels are poorly studied, palmitelaidic acid can have very different effects from those of palmitoleic acid... | |||
T36529 |
Palmitoleoyl Chloride
|
||
Palmitoleoyl Chloride 是棕榈油酸的衍生物,可用作合成多种化合物的中间体。 | |||
T37124 |
1,3-Dipalmitoleoyl-rac-glycerol
|
||
1,3-Dipalmitoleoyl-rac-glycerol is a diacylglycerol with palmitoleic acid at the sn-1 and sn-3 positions. It selectively inhibits α-glucosidase from S. cerevisiae over rat enzyme (IC50s = 4.45 and 9,326.5 μM, respectively). 1,3-Dipalmitoleoyl-rac-glycerol has been used in the formation of lipid bilayers to study the effects of membrane composition and the ionophore valinomycin on membrane potential. | |||
T35441 |
Tripalmitolein
|
||
Tripalmitolein is a triacylglycerol that contains palmitoleic acid at the sn-1, sn-2, and sn-3 positions. It reduces red blood cell deformability in a concentration-dependent manner in a Reid's filtration assay. Hepatic levels of 1,2,3-tripalmitoleoyl-rac-glycerol are increased in the JAK2L mouse model of hepatic steatosis. Tripalmitolein plasma levels are decreased in renal patients before dialysis. | |||
T74737 |
mono-Pal-MTO
|
||
Mono-Pal-MTO 是米托蒽醌 (MTO) 与棕榈酸结合的棕榈基脂质,其抗癌活性得以显著提升。当摩尔比1:1时,将mono-Pal-MTO与di-Pal-MTO的纳米颗粒组合使用,可有效递送siRNA至细胞内,进一步增强其抗癌效果。 | |||
T74738 |
di-Pal-MTO
|
||
di-Pal-MTO,一种棕榈油基脂质,由抗癌活性分子米托蒽醌(MTO)与棕榈油酸以1:1的摩尔比结合形成。当以纳米颗粒形式将mono-Pal-MTO与di-Pal-MTO联合使用时,能有效递送siRNA至细胞内,并显著增强抗癌活性。 | |||
T36590 |
9-PAHSA
|
||
Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are newly identified endogenous lipids regulated by fasting and high-fat feeding and associated with insulin sensitivity. Structurally, these esters are comprised of a C-16 or C-18 fatty acid (e.g., palmitoleic, palmitic, oleic, or stearic acid) linked to a hydroxylated C-16 or C-18 lipid. 9-PAHSA is a FAHFA in which palmitic acid is esterified to 9-hydroxy stearic acid. PAHSAs are the most abundant forms of FAHFA in serum as well as whi... | |||
T36586 |
12-PAHSA
|
||
Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are newly identified endogenous lipids regulated by fasting and high-fat feeding and associated with insulin sensitivity. Structurally, these esters are comprised of a C-16 or C-18 fatty acid (e.g., palmitoleic, palmitic, oleic, or stearic acid) linked to either a C-16 or C-18 hydroxy substituent. 12-PAHSA is a FAHFA in which palmitic acid is esterified at the 12th carbon of hydroxy stearic acid. Among the FAHFA family members, PAHSAs ar... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4872 |
Palmitoleic acid
棕榈油酸,(Z)-Hexadec-9-enoic acid,(Z)-9-hexadecenoic acid |
Endogenous Metabolite | Metabolism |
Palmitoleic acid ((Z)-Hexadec-9-enoic acid) 是脂肪酸的组成部分,能够预防 SHRSP 大鼠因脑血管疾病引起的死亡。 | |||
T19500 |
Palmitelaidic Acid
trans-Palmitoleic acid,9-trans-Hexadecenoic acid,软脂酸 |
Glucokinase; AMPK; PPAR | Chromatin/Epigenetic; DNA Damage/DNA Repair; Metabolism; PI3K/Akt/mTOR signaling |
trans-Palmitelaidic Acid (trans-Palmitoleic acid) 是palmitoleic acid 的反式异构体。Palmitoleic acid 是血清和组织中最丰富的脂肪酸之一。 | |||
T8276 |
Methyl palmitoleate
|
Others | Others |
Methyl palmitoleate 是棕榈油酸的类似物,也是一种脂肪酸甲酯,具有细胞保护性和促进生长性。 |